This finding is even more remarkable as CA-125 is explicitly stated by the European Group on Tumor Markers as a suitable biomarker in combination with other diagnostics for detection, monitoring and prognosis of serous ovarian carcinomas due to its relatively high concentrations [3]. This evidence concerns the gene MUC16 and ovarian serous carcinoma.